IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
ST-Segment Elevation Myocardial Infraction
Interventions
DRUG

Sodium Sulfide (Na2S) for Injection

IK-1001 is Na2S administered as an isotonic solution for intravenous (IV) injection or continuous infusion. IK-1001 will be administered as a 3-hour continuous IV infusion started \> 5 minutes but \< 20 minutes (approximately) prior to coronary artery reperfusion.

DRUG

Placebo

0.9% Sodium Chloride (NaCl) will be administered in the same manner as the experimental drug.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY